Increased likelihood of long-term gastrostomy tube dependence in head and neck cancer survivors without partners

Head and Neck

Volumn 35, Issue 3, 2013, Pages 420-425

  Magnuson, J Scott ^a   Durst, Jennifer ^a   Rosenthal, Eben L ^a   Carroll, William R ^a   Ritchie, Christine S ^b   Kilgore, Meredith L ^c   Locher, Julie L ^b,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

gastrostomy tubes; head and neck cancer; long term PEG dependence; social support; survivors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CHEMORADIOTHERAPY; FEMALE; FREE TISSUE GRAFT; GASTROTOMY; HEAD AND NECK CANCER; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY TUBE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; STOMACH TUBE; TRACHEOTOMY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GASTROSTOMY; HEAD AND NECK NEOPLASMS; HUMANS; INTUBATION, GASTROINTESTINAL; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SOCIAL SUPPORT; SURVIVORS;

EID: 84874116760     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.22996     Document Type: Article

References (43)

1. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578.
2. Mendenhall WM, Parsons JT,. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck. Cancer Invest 1998; 16: 594-603.
3. Parsons JT, Mendenhall WM, Cassisi NJ, Isaacs JH Jr, Million RR,. Hyperfractionation for head and neck cancer. Int J Radiat Oncol Biol Phys 1988; 14: 649-658.
4. Garden AS, Asper JA, Morrison WH, et al. Is concurrent chemoradiation the treatment of choice for all patients with state III or IV head and neck carcinoma? Cancer 2004; 100: 1171-1178.
5. Cohen EE, Lingen MW, Vokes EE,. The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 2004; 22: 1743-1752.
6. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798-1804.
7. Pignon JP, Bourhis J, Domenge C, Designé L,. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 2000; 355: 949-955.
8. Fu KK, Pajak TF, Trotti A, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48: 7-16.
9. Karnell LH, Christensen AJ, Rosenthal EL, Magnuson JL, Funk GF,. Influence of social support on health-related quality of life outcomes in head and neck cancer. Head Neck 2007; 29: 143-146.
10. Henk JM,. Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol (R Coll Radiol) 1997; 9: 308-312.
11. Pauloski BR, Logemann JA, Fox JC, Colangelo LA,. Biomechanical analysis of the pharyngeal swallow in postsurgical patients with anterior tongue and floor of mouth resection and distal flap reconstruction. J Speech Hear Res 1995; 38: 110-123.
12. Hillman RE, Walsh MJ, Wolf GT, Fisher SG, Hong WK,. Functional outcomes following treatment for advanced laryngeal cancer. Part I-Voice preservation in advanced laryngeal cancer. Part II-Laryngectomy rehabilitation: the state of the art in the VA System. Research speech-language pathologists. Department of veterans affairs laryngeal cancer study group. Ann Otol Rhinol Laryngol Suppl 1998; 172: 1-27.
13. Murry T, Madasu R, Martin A, Robbins KT,. Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck 1998; 20: 31-37.
14. Newman LA, Robbins KT, Logemann JA, et al. Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck 2002; 24: 68-77.
15. Newman LA, Vieira F, Schwiezer V, et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1998; 124: 589-592.
16. Adelstein DJ, Saxton JP, Lavertu P, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in respectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997; 19: 567-575.
17. Lazaras CL, Logemann JA, Pauloski BR, et al. Swallowing and tongue function following treatment for oral and oropharyngeal cancer. J Speech Lang Hear Res 2000; 43: 1011-1023.
18. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002; 35: 23-28.
19. Lazarus CL, Logemann JA, Pauloski BR, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996; 106 (9 Pt 1): 1157-1166.
20. Dejaeger E, Goethals P,. Deglutition disorder as a late sequel of radiotherapy for a pharyngeal tumor. Am J Gastroenterol 1995; 90: 493-495.
21. Kotz T, Abraham S, Beitler JJ, Wadler S, Smith RV,. Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg 1999; 125: 410-413.
22. Mittal BB, Pauloski BR, Haraf DJ, et al. Swallowing dysfunction- preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 2003; 57: 1219-1230.
23. Locher JL, Bonner JA, Carroll WR, et al. Prophylactic percutaneous endoscopic gastrostomy tube use in head and neck cancer patients: a comprehensive review and call for evidence-based practice. J Parenter Enteral Nutr 2011; 35: 365-374.
24. Locher JL, Bonner JA, Carroll WR, et al. Gastrostomy tube placement and use in patients with head and neck cancer. Head Neck 2012; 34: 422-428.
25. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
26. Caudell JJ, Schaner PE, Meredith RF, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009; 73: 410-415.
27. Jensen K, Lambertsen K, Grau C,. Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 2007; 85: 74-82.
28. Schweinfurth JM, Boger GN, Feustel PJ,. Preoperative risk assessment for gastrostomy tube placement in head and neck cancer patients. Head Neck 2001; 23: 376-382.
29. Gardine RL, Kokal WA, Beatty JD, Riihimaki DU, Wagman LD, Terz JJ,. Predicting the need for prolonged enteral supplementation in the patient with head and neck cancer. Am J Surg 1988; 156: 63-65.
30. Litton WB, Leonard RJ,. Aspiration after partial laryngectomy: cineradiographic studies. Laryngoscope 1969; 79: 887-908.
31. Konski AA, Pajak TF, Movsas B, et al. Disadvantage of men living alone participating in radiation therapy oncology group head and neck trials. J Clin Oncol 2006; 24: 4177-4183.
32. Sprehn GC, Chambers JE, Saykin AJ, Konski A, Johnstone PA,. Decreased cancer survival in individuals separated at time of diagnosis: critical period for cancer pathophysiology? Cancer 2009; 115: 5108-5116.
33. House JS, Landis KR, Umberson D,. Social relationships and health. Science 1988; 241: 540-545.
34. Thoits PA,. Stress, coping, and social support processes: where are we? what next? J Health Soc Behav 1995;Spec No: 53-79.
35. Locher JL, Robinson CO, Bailey FA, et al. The contribution of social factors to undereating in older adults with cancer. J Support Oncol 2009; 7: 168-173.
36. Locher JL, Robinson CO, Bailey FA, et al. Disruptions in the organization of meal preparation and consumption among older cancer patients and their family caregivers. Psychooncology 2010; 19: 967-974.
37. Harari PM, Ritter MA, Petereit DG, Mehta MP,. Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations. Curr Probl Cancer 2004; 28: 7-40.
38. Ravasco P, Monteiro-Grillo I, Vidal PM, Camilo ME,. Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol (R Coll Radiol) 2003; 15: 443-450.
39. Pauloski BR, Logeman JA, Rademaker AW, et al. Speech and swallowing function after oral and oropharyngeal resections: one-year follow-up. Head Neck 1994; 16: 313-322.
40. Zuydam AC, Lowe D, Brown JS, Vaughan ED, Rogers SN,. Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clin Otolaryngol 2005; 30: 428-437.
41. Leder SB, Joe JK, Ross DA, Coelho DH, Mendes J,. Presence of a tracheotomy tube and aspiration status in early, postsurgical head and neck cancer patients. Head Neck 2005; 27: 757-761.
42. Skoner JM, Andersen PE, Cohen JI, Holland JJ, Hansen E, Wax MK,. Swallowing function and tracheotomy dependence after combined-modality treatment including free tissue transfer for advanced-stage oropharyngeal cancer. Laryngoscope 2003; 113: 1294-1298.
43. Rieger JM, Zalmanowitz JG, Li SY, et al. Functional outcomes after surgical reconstruction of the base of tongue using the radial forearm free flap in patients with oropharyngeal carcinoma. Head Neck 2007; 29: 1024-1032.